Rik J. Scheper, Ph.D., is an immunologist and experimental pathologist in the Department of Pathology of VUmc in Amsterdam. Currently, after his nominal retirement in 2010, Rik J Scheper continues as an advisor and academic project and thesis promotor in the Departments of Pathology, Medical Oncology, and Dermatology of the VU University Medical Center, next to his contributions to two offspin companies focusing on advanced tissue medicinal products, DCPrime BV (tumor vaccine development) and ASkin BV (autologous cultured skin grafts).